- Laboratory data at diagnosis of dermatomyositis and at 2 months post-treatment.
| Parameters | At the time of diagnosis | Two months after treatment | Reference range |
|---|---|---|---|
| Hematology | |||
| Hgb (g/dl) | 12.5 | 13.9 | 13-18 |
| WBC (103/µl) | 3.41 | 4.2 | 4-11 |
| Lymphocytes (103/µl) | 0.810 | 1.4 | 1.5-4 |
| Platelets (103/µl) | 99 | 193 | 150-450 |
| Chemistry | |||
| Creatinine (µmol/L) | 69 | 61 | 71-115 |
| BUN (mmol/L) | 4.6 | 7 | 2.5-6.4 |
| CK | 9697 | 30 | 39-308 |
| AST | 517 | 27 | 15-37 |
| Serum troponin | 0.1302 | - | <0.026 |
| Albumin (g/L) | 20 | 36 | 34-50 |
| Serology | |||
| ANA (homogeneous) | 1:320 | - | Negative |
| Anti-Mi-2 | Negative | Negative | |
| Anti-Jo-1 | Negative | Negative | |
| Anti-RNP | Negative | Negative | |
| Anti-ds-DNA | Negative | - | Negative |
| HIV (ELISA) | Negative | Negative | |
| CRP | 41 | 0.5 | <6 |
| ESR | 18 | 10 | <15 (male) |
| 24-Hour urinary albumin | <0.300 | - | <0.300 |
| Tumor markers | |||
| Total PSA (ng /ml) | 2.1 | 0-4 | |
| CA19-9 (U/mL) | <7.76 | 0-37 | |
| CEA (ng/mL) | 1.98 | 0-5 | |
| Hgb: hemoglobin, WBC: white blood cell, BUN: blood urea nitrogen, CK: creatinine kinase, AST: aspartate aminotransferase,ANA: antinuclear antibody, CRP: C-reactive protein, ESR: erythrocyte sedimentation rate | |||